BEIJING MED-PHARM CORPORATION ENTERS INTO AGREEMENT REGARDING ACQUISITION OF MAJORITY INTEREST IN SHANGHAI PHARMACEUTICAL DISTRIBUTOR

Beijing Med-Pharm Corporation today announced that it has entered into an agreement with Shanghai CAS Shenglongda Biotech (Group) Co., Ltd. and Shanghai Rongheng International Trade Co. Ltd. of Orient International (Holding) Co. regarding its potential acquisition of a majority interest in Shanghai Rongheng Pharmaceutical Co., Ltd. ("Rongheng"), a pharmaceutical distribution enterprise with operations in Shanghai, China's largest city.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060512005212&newsLang=en)